SHANGHAI, Oct. 15, 2020 /PRNewswire/ -- The third China International Import Expo (CIIE) will be held in Shanghai from November 5th to 11th, ZEISS will consecutively participate in the CIIE for the third year. As an internationally leading technology enterprise operating in the fields of optics and optoelectronics, ZEISS will set a booth at the new "Public Health and Epidemic Prevention" exhibition area, focusing on exhibiting its multiple innovations and solutions in the fields of epidemic control research, disease diagnosis and treatment, and eye health.
The COVID-19 has impacted the world economy on multiple fronts this year, and attending this year's CIIE is of great significance to business development and deepening cooperation for ZEISS. "The third CIIE will inject a shot of cardiotonic to the global trade and provide an opportunity for international companies like ZEISS," said Maximilian Foerst, President & Managing Director of ZEISS Greater China. "ZEISS will showcase new technologies and new products this year, and work with partners to turn the crisis into an opportunity."
Boosting Pandemic Prevention and Control with Optical Technologies
The control of diseases, especially infectious diseases, has been an important topic in human's scientific research for hundreds of years. While the modern bacteriology research has brought indelible contribution for infectious diseases conquest. Back in the 19th century, Robert Koch, winner of the 1905 Nobel Prize in Physiology or Medicine, already studied infectious pathogens with a ZEISS microscope and proposed the famous Koch's postulates, which are still used as an important theory today in looking for viruses' pathogen. For nearly two centuries, ZEISS has never stopped helping mankind control epidemics with its optical technologies. During the COVID-19 pandemic, ZEISS' products like ZEISS Celldiscoverer 7 (a fully integrated high-end automated live cell imaging system) were used in virus studying and vaccines developing. All these products will be exhibited at this year's CIIE.
Meanwhile, ZEISS has been concerned about the safety of medical workers and has donated numerous protective products such as the slit lamp breath shields to use with ophthalmic equipment and infection proof cover for surgical equipment like ZEISS KINEVO 900. Meanwhile, ZEISS FORUM (a DICOM- based patient management system) has made contributions in assisting ophthalmologists with remote diagnosis during the COVID-19. In addition, ZEISS service provided customers with comprehensive remote maintenance services through professional remote system, escorting the front-line medical workers during the epidemic.
Protecting Public Eye Health through Innovation
Eye health is one of the major issues in public health. Juvenile myopia and many other eye diseases seriously affect people's health and quality of life. ZEISS has been committed to protecting eye health for a long time. With more than 100 years' experience in ophthalmology and optometry, ZEISS has been helping eye health development in China by strengthening public education, improving people's awareness about eye health, and providing innovative products, mature solutions and strong technical support. At this year's CIIE, ZEISS will showcase its innovative and breakthrough technologies in eye health including ZEISS VisuMax, ZEISS CLARUS 500, and other ophthalmic systems.
In response to the national strategic plan of "Healthy China 2030", ZEISS has launched programs specifically prepared for the China market such as the "ZEISS Institute for Myopia Prevention and Control" and "Vision in County", to address ametropia in adolescents and cataract blindness for people in poverty. As in the last year of the 13th Five-year Plan Period for eye health, ZEISS will touch base with industry partners at the CIIE, and work together to help improve the prevention, diagnosis, treatment and rehabilitation of eye diseases as well as health education in China on an ongoing basis.
ZEISS' booth will be located at Booth B01-005, Medial Equipment & Health Care Products Exhibition Area. During this year's CIIE, ZEISS will make joint efforts both online and offline, to let people across the country learn more about ZEISS from home through live streaming as well as through social mini programs like ZEISS MINISITE. As an optical company with a history of almost 175 years, ZEISS will again bring its cutting-edge technologies and innovative products to China market and the Chinese consumers through the third CIIE to actively increase people's visual health quality. Meanwhile, to help accelerate the progress of medical and health industry, and make contributions to the realization of the national strategic plan of "Healthy China 2030".
About ZEISS
ZEISS is an internationally leading technology enterprise operating in the fields of optics and optoelectronics. In the previous fiscal year, the ZEISS Group generated annual revenue totaling more than 6.4 billion euros in its four segments Semiconductor Manufacturing Technology, Industrial Quality & Research, Medical Technology and Consumer Markets (status: 30 September 2019).
For its customers, ZEISS develops, produces and distributes highly innovative solutions for industrial metrology and quality assurance, microscopy solutions for the life sciences and materials research, and medical technology solutions for diagnostics and treatment in ophthalmology and microsurgery. The name ZEISS is also synonymous with the world's leading lithography optics, which are used by the chip industry to manufacture semiconductor components. There is global demand for trendsetting ZEISS brand products such as eyeglass lenses, camera lenses and binoculars.
With a portfolio aligned with future growth areas like digitalization, healthcare and Smart Production and a strong brand, ZEISS is shaping the future of technology and constantly advancing the world of optics and related fields with its solutions. The company's significant, sustainable investments in research and development lay the foundation for the success and continued expansion of ZEISS' technology and market leadership.
With over 31,000 employees, ZEISS is active globally in almost 50 countries with around 60 sales and service companies, 30 production sites and 25 development sites. Founded in 1846 in Jena, the company is headquartered in Oberkochen, Germany. The Carl Zeiss Foundation, one of the largest foundations in Germany committed to the promotion of science, is the sole owner of the holding company, Carl Zeiss AG
Further information at www.zeiss.com
ZEISS in Greater China
ZEISS' history in Greater China dates back to 1957. ZEISS is now represented in Greater China market with all segments including Semiconductor Manufacturing Technology, Industry Quality & Research, Medical Technology, and Consumer Markets. China is one of the fast growing regions of the ZEISS Group. 4,000 employees through up the country with 6 factories and 4 sales and service offices strongly support our customers in the region, and guarantee every related business internationally.
The headquarters of ZEISS Greater China locates in Shanghai Pilot Free Trade Zone. It is home to a wide range of activities: China Sales & Service headquarters for the Medical Technology, competence and training center, manufacturing facility for the ZEISS Industrial Quality Solutions business group and the Group's first corporate innovation and research and development center outside of Germany. We commit to support domestic R&D and production, positively expand cooperation fields to cultivate Chinese market in depth.
For details, please visit ZEISS China official website: http://www.zeiss.com.cn
Photo - https://photos.prnasia.com/prnh/20201015/2950894-1-a?lang=0
Photo - https://photos.prnasia.com/prnh/20201015/2950894-1-b?lang=0
Photo - https://photos.prnasia.com/prnh/20201015/2950894-1-c?lang=0
